17 Sept 2014director interest notice● Neutral
Lazarus Israel Opportunities Fund Lllp became a GB SCIENCES INC company insider (initial ownership filing).
Announcements, explained
Each one in plain English, with the numbers worked through for a shareholder.
14 Aug 2014quarterly activities report▼ Bad
GB SCIENCES INC reported a quarterly net loss of $1.4 million for the period ended 2014-06-30.
4 Aug 2014director interest notice● Neutral
GB SCIENCES INC 10%+ owner Lazarus Israel Opportunities Fund Lllp bought 39,800 shares on the open market.
30 July 2014director interest notice● Neutral
GB SCIENCES INC 10%+ owner Lazarus Israel Opportunities Fund Lllp bought 87,077 shares on the open market.
25 July 2014securities registration● Neutral
GB SCIENCES INC registered a securities offering with the SEC.
25 July 2014securities registration● Neutral
GB SCIENCES INC registered a securities offering with the SEC using its shelf eligibility.
2 July 2014director interest notice● Neutral
GB SCIENCES INC 10%+ owner Lazarus Investment Partners Lllp bought 269,632 shares on the open market.
9 June 2014capital raising announcement● NeutralMajor
The company sold 10,000,000 units at $0.50 each to 57 people (each unit one share plus A and B warrants) and issued 1,500,000 shares to cancel $390,000 of debt. Shares outstanding reach 23,331,932, and the address is now Las Vegas, Nevada. At the stated price the unit sale is about $5 million (calculated), a large increase in shares and potential warrant dilution.
5 June 2014securities registration● Neutral
GB SCIENCES INC filed notice of an exempt private placement.
4 June 2014director interest notice● Neutral
GB SCIENCES INC 10%+ owner Lazarus Management CO LLC bought 3,000,000 shares on the open market.
4 June 2014director interest notice● Neutral
Lazarus Israel Opportunities Fund Lllp became a GB SCIENCES INC 10%+ owner and company insider (initial ownership filing).
4 June 2014director interest notice● Neutral
Lazarus Investment Partners Lllp became a GB SCIENCES INC 10%+ owner and company insider (initial ownership filing).
9 May 2014capital raising announcement● Neutral
Since May 5, 2014 the company issued 1,755,612 shares to three entities to cancel $459,970 of debt, bringing shares outstanding to 16,305,652. Debt falls, but existing holders are diluted.
2 May 2014capital raising announcement● NeutralMajor
The company now files as GrowBlox Sciences, Inc. (formerly Signature Exploration and Production Corp.). Following the Ellins agreement, he received a further four million shares on May 1, 2014 after the company raised at least $1,000,000. Shares outstanding are 13,705,598 as of May 2, 2014.
1 Apr 2014capital raising announcement● Neutral
Since March 25, 2014 the company issued 438,681 shares to five people in exchange for cancelling $114,017.08 of debt, leaving 5,988,791 shares outstanding. This reduces debt but adds shares for existing holders.
1 Apr 2014securities registration● Neutral
GB SCIENCES INC filed notice of an exempt private placement.
27 Mar 2014capital raising announcement● Neutral
On March 21, 2014 the company sold 200,000 units to one person at $0.50 per unit, each unit being one share plus an A warrant and a B warrant. That is $100,000 at the stated price (calculated), with extra dilution if the warrants are exercised.
What it means for a shareholder
200,000 new shares at US$0.500 to raise about US$100,000. That's 19% dilution: every existing holder's slice gets 19% smaller. If you held US$1,000 of shares (2,000 at the issue price), your slice goes from 0.235% to 0.19% of the company. To keep it you'd need 471 more shares - about US$236 at the issue price.
Create a free account to see this worked out for your own holding.
19 Mar 2014business combination● Neutral
This amendment only corrects the phone and fax numbers on the front page of the March 2014 Ellins asset-acquisition filing; the rest restates the original (12,500,000 shares for cannabis assets, change of control to Ellins).
19 Mar 2014business combination● NeutralMajor
On March 13, 2014 the company agreed to buy cannabis-production assets (a provisional patent application, trade secrets, equipment, trademarks and more) from Craig Ellins for 12,500,000 restricted shares, 4,500,000 issued now and the rest on milestones. The 4,500,000 shares gave Ellins about 84% of the voting capital (per the filing) and he became CEO and Chairman; Steven Weldon stepped down as CEO but stays CFO. This is a change of control and a move away from oil and gas into cannabis; the earlier controllers, Weldon and Screaming Reach, held 52% beforehand.
14 Feb 2014quarterly activities report▼ Bad
GB SCIENCES INC reported a quarterly net loss of $183 thousand for the period ended 2013-12-31.
14 Nov 2013quarterly activities report● Neutral
GB SCIENCES INC reported a quarterly net income of $274 thousand for the period ended 2013-09-30.
14 Aug 2013late filing notice▼ Bad
GB SCIENCES INC notified the SEC that its quarterly report would be filed late.
16 July 2013auditor change● Neutral
On June 25, 2013 the board engaged LJ Sullivan Certified Public Accountant, LLC as auditor for the fiscal year ending March 31, 2013, replacing Mark Bailey and Company, which resigned in March. The filing says there was no prior consultation with the new firm. The address shown is back in Orlando, Florida.
1 July 2013late filing notice▼ Bad
GB SCIENCES INC notified the SEC that its annual report would be filed late.
15 Mar 2013auditor change▼ Bad
On March 8, 2013 auditor Mark Bailey and Company resigned. Its reports for fiscal 2011 and 2012 carried going-concern doubt because of losses since inception; the filing reports no disagreements with the company and no reportable events.
14 Feb 2013late filing notice▼ Bad
GB SCIENCES INC notified the SEC that its quarterly report would be filed late.
14 Nov 2012late filing notice▼ Bad
GB SCIENCES INC notified the SEC that its quarterly report would be filed late.
24 Aug 2012quarterly activities report● Neutral
GB SCIENCES INC reported a quarterly net income of $335 thousand for the period ended 2012-06-30.
20 Aug 2012quarterly activities report● Neutral
GB SCIENCES INC reported a quarterly net income of $335 thousand for the period ended 2012-06-30.
14 Aug 2012late filing notice▼ Bad
GB SCIENCES INC notified the SEC that its quarterly report would be filed late.